Skip to main content
NCBI home page
The BMJ logoLink to The BMJ
. 1996 Jan 27;312(7025):210–211. doi: 10.1136/bmj.312.7025.210

Commentary: non-HIV hypotheses must be studied more carefully.

P Duesberg 1
PMCID: PMC2350003  PMID: 8563583

Full text

PDF
210

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Chorba T. L., Holman R. C., Strine T. W., Clarke M. J., Evatt B. L. Changes in longevity and causes of death among persons with hemophilia A. Am J Hematol. 1994 Feb;45(2):112–121. doi: 10.1002/ajh.2830450204. [DOI] [PubMed] [Google Scholar]
  2. Cohen J. Researchers air alternative views on how HIV kills cells. Science. 1995 Aug 25;269(5227):1044–1045. doi: 10.1126/science.7652551. [DOI] [PubMed] [Google Scholar]
  3. Darby S. C., Ewart D. W., Giangrande P. L., Dolin P. J., Spooner R. J., Rizza C. R. Mortality before and after HIV infection in the complete UK population of haemophiliacs. UK Haemophilia Centre Directors' Organisation. Nature. 1995 Sep 7;377(6544):79–82. doi: 10.1038/377079a0. [DOI] [PubMed] [Google Scholar]
  4. Duesberg P. H. Foreign-protein-mediated immunodeficiency in hemophiliacs with and without HIV. Genetica. 1995;95(1-3):51–70. doi: 10.1007/BF01435001. [DOI] [PubMed] [Google Scholar]
  5. Duesberg P. H. Is HIV the cause of AIDS? Lancet. 1995 Nov 18;346(8986):1371–1372. doi: 10.1016/s0140-6736(95)92389-6. [DOI] [PubMed] [Google Scholar]
  6. Goedert J. J., Cohen A. R., Kessler C. M., Eichinger S., Seremetis S. V., Rabkin C. S., Yellin F. J., Rosenberg P. S., Aledort L. M. Risks of immunodeficiency, AIDS, and death related to purity of factor VIII concentrate. Multicenter Hemophilia Cohort Study. Lancet. 1994 Sep 17;344(8925):791–792. doi: 10.1016/s0140-6736(94)92345-0. [DOI] [PubMed] [Google Scholar]
  7. Kreiss J. K., Kasper C. K., Fahey J. L., Weaver M., Visscher B. R., Stewart J. A., Lawrence D. N. Nontransmission of T-cell subset abnormalities from hemophiliacs to their spouses. JAMA. 1984 Mar 16;251(11):1450–1454. [PubMed] [Google Scholar]
  8. Sabin C. A., Pasi K. J., Phillips A. N., Lilley P., Bofill M., Lee C. A. Comparison of immunodeficiency and AIDS defining conditions in HIV negative and HIV positive men with haemophilia A. BMJ. 1996 Jan 27;312(7025):207–210. doi: 10.1136/bmj.312.7025.207. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Seremetis S. V., Aledort L. M., Bergman G. E., Bona R., Bray G., Brettler D., Eyster M. E., Kessler C., Lau T. S., Lusher J. Three-year randomised study of high-purity or intermediate-purity factor VIII concentrates in symptom-free HIV-seropositive haemophiliacs: effects on immune status. Lancet. 1993 Sep 18;342(8873):700–703. doi: 10.1016/0140-6736(93)91706-r. [DOI] [PubMed] [Google Scholar]
  10. de Biasi R., Rocino A., Miraglia E., Mastrullo L., Quirino A. A. The impact of a very high purity factor VIII concentrate on the immune system of human immunodeficiency virus-infected hemophiliacs: a randomized, prospective, two-year comparison with an intermediate purity concentrate. Blood. 1991 Oct 15;78(8):1919–1922. [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES